Genomics – the study of all of a person's genes – is set to play an important role in the tailored healthcare future, but it is a difficult undertaking to apply genomic analysis at scale. Nest Genomics provides a platform to enable genetic information to become a part of everyday healthcare, contributing to making personalized medicine a reality.
Although genetic testing is better and cheaper than ever before, it remains unemployed in general clinical practice. With Nest’s software, a patient’s genetic information is taken into account alongside other data from their electronic health report, to generate care plans based on guidelines from speciality societies such as the American College of Medical Genetics and Genomics. These plans tackle health concerns such as hereditary cancers, and cardiovascular genetics.
Nest Genomic’s platform is built for genetic counsellors as well as primary care physicians, and includes a patient companion tool to help people understand and follow their care plans. The company has seen good levels of investment, including from YCombinator, which will go towards further developing its Clinical Decision Support product for scaling genetics-based care.
Kirsty
Company Specialist at Welcome to the Jungle
